Lingao Ju

27PUBLICATIONS
17CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer cell biologyCancer geneticsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Apr 03, 2025
RNF112 Facilitates Ubiquitin-Mediated Degradation of c-Myc, Suppressing Proliferation, Migration and Lipid Synthesis in Bladder Cancer.

Kangping Xiong, Siming Chen, Huimin Xu

|Nov 09, 2024
Mevalonate pathway inhibition reduces bladder cancer metastasis by modulating RhoB protein stability and integrin β1 localization.

Gang Wang, Tianchen Peng, Liang Chen

|Oct 11, 2024
Deubiquitylase USP52 Promotes Bladder Cancer Progression by Modulating Ferroptosis through Stabilizing SLC7A11/xCT.

Jianmin Liu, Yongwen Luo, Siming Chen

|Aug 07, 2024
Unveiling the association between HMG-CoA reductase inhibitors and bladder cancer: a comprehensive analysis using Mendelian randomization, animal models, and transcriptomics.

Houyi Wei, Zhilong Li, Kaiyu Qian

|May 09, 2024
Tracking single-cell evolution using clock-like chromatin accessibility loci.

Yu Xiao, Wan Jin, Lingao Ju

|Feb 29, 2024
Parkin inhibits proliferation and migration of bladder cancer via ubiquitinating Catalase.

Renjie Zhang, Wenyu Jiang, Gang Wang

Pageof 5

Frequent Collaborators

21 joint publications

Yu Xiao

20 joint publications

Xinghuan Wang

16 joint publications

Kaiyu Qian

12 joint publications

Yi Zhang